Tong Mook Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tong Mook Kang has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Sung Joon Kim
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
14 shared publications Insuk So
Center for Bio‐Artificial Muscle, Department of Biomedical Engineering, Hanyang University, Seoul (Korea), Fax: +82‐2‐2291‐2320
13 shared publicationsChang Kee Lee
6 shared publicationsKi Whan Kim
Department of Physiology & Biophysics, Seoul National University, College of Medicine, Seoul, Korea
6 shared publicationsSun I. Kim
6 shared publicationsJieun An
Department of Physiology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Suwon, Korea
5 shared publications
Latest Publications
- 22 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 699, 149561
Calcium homeostasis modulator 2 (Calhm2) as slowly activating membrane current channel in mouse B cells
- 22 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 699, 149561
Calcium homeostasis modulator 2 (Calhm2) as slowly activating membrane current channel in mouse B cells
- Open Access
- 28 July 2021
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 53 (7) , 1192-1204
Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss
Loss-of-function variant in the gene encoding the KCNQ4 potassium channel causes autosomal dominant nonsyndromic hearing loss (DFNA2), and no effective pharmacotherapeutics have been developed to reverse channel activity impairment. Phosphatidylinositol 4,5-bisphosphate (PIP2), an obligatory phospholipid for maintaining KCNQ channel activity, confers differential pharmacological sensitivity of channels to KCNQ openers. Through whole-exome sequencing of DFNA2 families, we identified three novel KCNQ4 variants related to diverse auditory phenotypes in the proximal C-terminus (p.Arg331Gln), the C-terminus of the S6 segment (p.Gly319Asp), and the pore region (p.Ala271_Asp272del). Potassium currents in HEK293T cells expressing each KCNQ4 variant were recorded by patch-clamp, and functional recovery by PIP2 expression or KCNQ openers was examined. In the homomeric expression setting, the three novel KCNQ4 mutant proteins lost conductance and were unresponsive to KCNQ openers or PIP2 expression. Loss of p.Arg331Gln conductance was slightly restored by a tandem concatemer channel (WT-p.R331Q), and increased PIP2 expression further increased the concatemer current to the level of the WT channel. Strikingly, an impaired homomeric p.Gly319Asp channel exhibited hyperactivity when a concatemer (WT-p.G319D), with a negative shift in the voltage dependence of activation. Correspondingly, a KCNQ inhibitor and chelation of PIP2 effectively downregulated the hyperactive WT-p.G319D concatemer channel. Conversely, the pore-region variant (p.Ala271_Asp272del) was nonrescuable under any condition. Collectively, these novel KCNQ4 variants may constitute therapeutic targets that can be manipulated by the PIP2 level and KCNQ-regulating drugs under the physiological context of heterozygous expression. Our research contributes to the establishment of a genotype/mechanism-based therapeutic portfolio for DFNA2.
- 28 July 2021
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 53 (7) , 1192-1204
Open AccessNovel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss
Loss-of-function variant in the gene encoding the KCNQ4 potassium channel causes autosomal dominant nonsyndromic hearing loss (DFNA2), and no effective pharmacotherapeutics have been developed to reverse channel activity impairment. Phosphatidylinositol 4,5-bisphosphate (PIP2), an obligatory phospholipid for maintaining KCNQ channel activity, confers differential pharmacological sensitivity of channels to KCNQ openers. Through whole-exome sequencing of DFNA2 families, we identified three novel KCNQ4 variants related to diverse auditory phenotypes in the proximal C-terminus (p.Arg331Gln), the C-terminus of the S6 segment (p.Gly319Asp), and the pore region (p.Ala271_Asp272del). Potassium currents in HEK293T cells expressing each KCNQ4 variant were recorded by patch-clamp, and functional recovery by PIP2 expression or KCNQ openers was examined. In the homomeric expression setting, the three novel KCNQ4 mutant proteins lost conductance and were unresponsive to KCNQ openers or PIP2 expression. Loss of p.Arg331Gln conductance was slightly restored by a tandem concatemer channel (WT-p.R331Q), and increased PIP2 expression further increased the concatemer current to the level of the WT channel. Strikingly, an impaired homomeric p.Gly319Asp channel exhibited hyperactivity when a concatemer (WT-p.G319D), with a negative shift in the voltage dependence of activation. Correspondingly, a KCNQ inhibitor and chelation of PIP2 effectively downregulated the hyperactive WT-p.G319D concatemer channel. Conversely, the pore-region variant (p.Ala271_Asp272del) was nonrescuable under any condition. Collectively, these novel KCNQ4 variants may constitute therapeutic targets that can be manipulated by the PIP2 level and KCNQ-regulating drugs under the physiological context of heterozygous expression. Our research contributes to the establishment of a genotype/mechanism-based therapeutic portfolio for DFNA2.
- Open Access
- 1 November 2020
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 24 (6) , 529-543
Nanoscale imaging of rat atrial myocytes by scanning ion conductance microscopy reveals heterogeneity of T-tubule openings and ultrastructure of the cell membrane
Sun Hwa Park, Ami Kim, Jieun An, Hyun Sung Cho, and Tong Mook Kang. Korean J Physiol Pharmacol 2020;24:529-43. https://doi.org/10.4196/kjpp.2020.24.6.529
- 1 November 2020
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 24 (6) , 529-543
Open AccessNanoscale imaging of rat atrial myocytes by scanning ion conductance microscopy reveals heterogeneity of T-tubule openings and ultrastructure of the cell membrane
Sun Hwa Park, Ami Kim, Jieun An, Hyun Sung Cho, and Tong Mook Kang. Korean J Physiol Pharmacol 2020;24:529-43. https://doi.org/10.4196/kjpp.2020.24.6.529
- 5 September 2019
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 471 (10) , 1245-1246
Unconventional eNOS in pulmonary artery smooth muscles: why should it be there?
- 5 September 2019
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 471 (10) , 1245-1246
Unconventional eNOS in pulmonary artery smooth muscles: why should it be there?
- Open Access
- 1 January 2019
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 23 (6) , 539-547
Deficiency of Anoctamin 5/TMEM16E causes nuclear positioning defect and impairs Ca2+ signaling of differentiated C2C12 myotubes
Phuong TT, et al. Korean J Physiol Pharmacol. 2019 Nov;23(6):539-547. https://doi.org/10.4196/kjpp.2019.23.6.539
- 1 January 2019
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 23 (6) , 539-547
Open AccessDeficiency of Anoctamin 5/TMEM16E causes nuclear positioning defect and impairs Ca2+ signaling of differentiated C2C12 myotubes
Phuong TT, et al. Korean J Physiol Pharmacol. 2019 Nov;23(6):539-547. https://doi.org/10.4196/kjpp.2019.23.6.539
- Open Access
- 9 November 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Whole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss
Mutations in potassium voltage-gated channel subfamily Q member 4 (KCNQ4) are etiologically linked to a type of nonsyndromic hearing loss, deafness nonsyndromic autosomal dominant 2 (DFNA2). We performed whole-exome sequencing for 98 families with hearing loss and found mutations in KCNQ4 in five families. In this study, we characterized two novel mutations in KCNQ4: a missense mutation (c.796G>T; p.Asp266Tyr) and an in-frame deletion mutation (c.259_267del; p.Val87_Asn89del). p.Asp266Tyr located in the channel pore region resulted in early onset and moderate hearing loss, whereas p.Val87_Asn89del located in the N-terminal cytoplasmic region resulted in late onset and high frequency-specific hearing loss. When heterologously expressed in HEK 293 T cells, both mutant proteins did not show defects in protein trafficking to the plasma membrane or in interactions with wild-type (WT) KCNQ4 channels. Patch-clamp analysis demonstrated that both p.Asp266Tyr and p.Val87_Asn89del mutant channels lost conductance and were completely unresponsive to KCNQ activators, such as retigabine, zinc pyrithione, and ML213. Channels assembled from WT-p.Asp266Tyr concatemers, like those from WT-WT concatemers, exhibited conductance and responsiveness to KCNQ activators. However, channels assembled from WT-p.Val87_Asn89del concatemers showed impaired conductance, suggesting that p.Val87_Asn89del caused complete loss-of-function with a strong dominant-negative effect on functional WT channels. Therefore, the main pathological mechanism may be related to loss of K+ channel activity, not defects in trafficking.
- 9 November 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Open AccessWhole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss
Mutations in potassium voltage-gated channel subfamily Q member 4 (KCNQ4) are etiologically linked to a type of nonsyndromic hearing loss, deafness nonsyndromic autosomal dominant 2 (DFNA2). We performed whole-exome sequencing for 98 families with hearing loss and found mutations in KCNQ4 in five families. In this study, we characterized two novel mutations in KCNQ4: a missense mutation (c.796G>T; p.Asp266Tyr) and an in-frame deletion mutation (c.259_267del; p.Val87_Asn89del). p.Asp266Tyr located in the channel pore region resulted in early onset and moderate hearing loss, whereas p.Val87_Asn89del located in the N-terminal cytoplasmic region resulted in late onset and high frequency-specific hearing loss. When heterologously expressed in HEK 293 T cells, both mutant proteins did not show defects in protein trafficking to the plasma membrane or in interactions with wild-type (WT) KCNQ4 channels. Patch-clamp analysis demonstrated that both p.Asp266Tyr and p.Val87_Asn89del mutant channels lost conductance and were completely unresponsive to KCNQ activators, such as retigabine, zinc pyrithione, and ML213. Channels assembled from WT-p.Asp266Tyr concatemers, like those from WT-WT concatemers, exhibited conductance and responsiveness to KCNQ activators. However, channels assembled from WT-p.Val87_Asn89del concatemers showed impaired conductance, suggesting that p.Val87_Asn89del caused complete loss-of-function with a strong dominant-negative effect on functional WT channels. Therefore, the main pathological mechanism may be related to loss of K+ channel activity, not defects in trafficking.
- Open Access
- 31 March 2017
- Published by Sungkyunkwan University School of Medicine in Precision and Future Medicine
- Vol. 1 (1) , 1-2
Welcome to the new journal, Precision and Future Medicine
- 31 March 2017
- Published by Sungkyunkwan University School of Medicine in Precision and Future Medicine
- Vol. 1 (1) , 1-2
Open AccessWelcome to the new journal, Precision and Future Medicine
- Open Access
- 25 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26687
Bio-inspired Hybrid Carbon Nanotube Muscles
There has been continuous progress in the development for biomedical engineering systems of hybrid muscle generated by combining skeletal muscle and artificial structure. The main factor affecting the actuation performance of hybrid muscle relies on the compatibility between living cells and their muscle scaffolds during cell culture. Here, we developed a hybrid muscle powered by C2C12 skeletal muscle cells based on the functionalized multi-walled carbon nanotubes (MWCNT) sheets coated with poly(3,4-ethylenedioxythiophene) (PEDOT) to achieve biomimetic actuation. This hydrophilic hybrid muscle is physically durable in solution and responds to electric field stimulation with flexible movement. Furthermore, the biomimetic actuation when controlled by electric field stimulation results in movement similar to that of the hornworm by patterned cell culture method. The contraction and relaxation behavior of the PEDOT/MWCNT-based hybrid muscle is similar to that of the single myotube movement, but has faster relaxation kinetics because of the shape-maintenance properties of the freestanding PEDOT/MWCNT sheets in solution. Our development provides the potential possibility for substantial innovation in the next generation of cell-based biohybrid microsystems.
- 25 May 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 26687
Open AccessBio-inspired Hybrid Carbon Nanotube Muscles
There has been continuous progress in the development for biomedical engineering systems of hybrid muscle generated by combining skeletal muscle and artificial structure. The main factor affecting the actuation performance of hybrid muscle relies on the compatibility between living cells and their muscle scaffolds during cell culture. Here, we developed a hybrid muscle powered by C2C12 skeletal muscle cells based on the functionalized multi-walled carbon nanotubes (MWCNT) sheets coated with poly(3,4-ethylenedioxythiophene) (PEDOT) to achieve biomimetic actuation. This hydrophilic hybrid muscle is physically durable in solution and responds to electric field stimulation with flexible movement. Furthermore, the biomimetic actuation when controlled by electric field stimulation results in movement similar to that of the hornworm by patterned cell culture method. The contraction and relaxation behavior of the PEDOT/MWCNT-based hybrid muscle is similar to that of the single myotube movement, but has faster relaxation kinetics because of the shape-maintenance properties of the freestanding PEDOT/MWCNT sheets in solution. Our development provides the potential possibility for substantial innovation in the next generation of cell-based biohybrid microsystems.
- Open Access
- 18 September 2015
- Published by Elsevier in Integrative Medicine Research
- Vol. 4 (4) , 242-248
Stromal interaction molecule 2 regulates C2C12 myoblast differentiation
- 18 September 2015
- Published by Elsevier in Integrative Medicine Research
- Vol. 4 (4) , 242-248
Open AccessStromal interaction molecule 2 regulates C2C12 myoblast differentiation
- Open Access
- 30 September 2013
- Published by Elsevier in Integrative Medicine Research
- Vol. 2 (3) , 112-123
Activation of rat transient receptor potential cation channel subfamily V member 1 channels by 2-aminoethoxydiphenyl borate
- 30 September 2013
- Published by Elsevier in Integrative Medicine Research
- Vol. 2 (3) , 112-123
Open AccessActivation of rat transient receptor potential cation channel subfamily V member 1 channels by 2-aminoethoxydiphenyl borate